Prediction of prostate cancer risk: The role of prostate volume and digital rectal examination in the ERSPC risk calculators

European Urology

Volumn 61, Issue 3, 2012, Pages 577-583

  Roobol, Monique J ^a   Van Vugt, Heidi A ^a   Loeb, Stacy ^b   Zhu, Xiaoye ^a   Bul, Meelan ^a   Bangma, Chris H ^a   Van Leenders, Arno G L J H ^a   Steyerberg, Ewout W ^a   Schröder, Fritz H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biopsy; Prostate cancer; Prostate volume; Rectal examination; Risk calculator; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; DIGITAL RECTAL EXAMINATION; EUROPE; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE; PROSTATE BIOPSY; PROSTATE CANCER; RISK ASSESSMENT; TRANSRECTAL ULTRASONOGRAPHY; VALIDATION STUDY;

AGED; AREA UNDER CURVE; BIOPSY; COHORT STUDIES; DIGITAL RECTAL EXAMINATION; EARLY DETECTION OF CANCER; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK;

EID: 84856380113     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.11.012     Document Type: Article

References (22)

1. F. Schröder, and M.W. Kattan The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review Eur Urol 54 2008 274 290
2. R. Kranse, M. Roobol, and F.H. Schröder A graphical device to represent the outcomes of a logistic regression analysis Prostate 68 2008 1674 1680
3. E.W. Steyerberg, M.J. Roobol, M.W. Kattan, T.H. van der Kwast, H.J. de Koning, and F.H. Schröder Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram J Urol 177 2007 107 112 discussion 112 (Pubitemid 44879468)
4. A.M. Bohnen, F.P. Groeneveld, and J.L.H.R. Bosch Serum prostate-specific antigen as a predictor of prostate volume in the community: the Krimpen study Eur Urol 51 2007 1645 1653 discussion 1652-3 (Pubitemid 46634760)
5. C.G. Roehrborn, P. Boyle, A.L. Gould, and J. Waldstreicher Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia Urology 53 1999 581 589 (Pubitemid 29136206)
6. C.G. Roehrborn, C.J. Girman, and T. Rhodes Correlation between prostate size estimated bydigital rectal examination and measured by transrectal ultrasound Urology 49 1997 548 557 (Pubitemid 27161413)
7. J.L.H.R. Bosch, A.M. Bohnen, and F.P.M.J. Groeneveld Validity of digital rectal examination and serum prostate specific antigen in the estimation of prostate volume in community-based men aged 50 to 78 years: the Krimpen study Eur Urol 46 2004 753 759 (Pubitemid 39488407)
8. M.J. Roobol, W.J. Kirkels, and F.H. Schröder Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands) BJU Int 92 Suppl 2 2003 48 54 (Pubitemid 38091140)
9. E.W. Steyerberg, A.J. Vickers, and N.R. Cook Assessing the performance of prediction models: a framework for traditional and novel measures Epidemiology 21 2010 128 138
10. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
11. I.M. Thompson, D.P. Ankerst, and C. Chi Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial J Natl Cancer Inst 98 2006 529 534 (Pubitemid 43898816)
12. Trottier G, Roobol MJ, Lawrentschuk N, et al. Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort. BJU Int. In press. doi:10.1111/j.1464-410X.2011.10207.x.
13. V. Cavadas, L. Osório, and F. Sabell Prostate cancer prevention trial and European randomized study of screening for prostate cancer risk calculators: a performance comparison in a contemporary screened cohort Eur Urol 58 2010 551 558
14. D.V. Makarov, S. Loeb, R.H. Getzenberg, and A.W. Partin Biomarkers for prostate cancer Annu Rev Med 60 2009 139 151
15. S. Loeb, M. Han, K.A. Roehl, J.A. Antenor, and W.J. Catalona Accuracy of prostate weight estimation by digital rectal examination versus transrectal ultrasonography J Urol 173 2005 63 65 (Pubitemid 39627672)
16. M. Ghafoori, P. Varedi, S.J. Hosseini, M. Asgari, and M. Shakiba Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men Urol J 6 2009 182 188
17. S.J. Freedland, W.B. Isaacs, and E.A. Platz Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study J Clin Oncol 23 2005 7546 7554 (Pubitemid 46291818)
18. J.I. Epstein, P.C. Walsh, M. Carmichael, and C.B. Brendler Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368 374 (Pubitemid 24037911)
19. Ko JS, Landis P, Carter HB, Partin AW. Effect of intra-observer variation in prostate volume measurement on prostate-specific antigen density calculations among prostate cancer active surveillance participants. BJU Int 2011. In press. doi:10.1111/j.1464-410X.2011.10223.x.
20. W.C. Cheng, F.C. Ng, and K.C. Chan Interobserver variation of prostatic volume estimation with digital rectal examination by urological staffs with different experiences Int Braz J Urol 30 2004 466 471
21. H. Miyake, T. Kurahashi, A. Takenaka, I. Hara, and M. Fujisawa Improved accuracy for predicting the Gleason score of prostate cancer by increasing the number of transrectal biopsy cores Urol Int 79 2007 302 306 (Pubitemid 350136514)
22. I.F. San Francisco, W.C. DeWolf, S. Rosen, M. Upton, and A.F. Olumi Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy J Urol 169 2003 136 140 (Pubitemid 35461571)